O
Opthea Ltd
OTC:CYVNY
Opthea Ltd
OTC:CYVNY
Price:
0.015
USD
Market Closed
Market Cap:
$20.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently viewed
Price
Intrinsic Value
Not Available for CYVNY
There is not enough data to reliably calculate the intrinsic value for Opthea Ltd.
Do our valuations actually work? See backtest results .
Alternatives to CYVNY
Fundamental Analysis
What Opthea Does
Opthea Ltd is a biotechnology company that develops eye-disease medicines, with its main focus on treatments for retinal diseases such as wet age-related macular degeneration and diabetic macular edema. Its lead drug candidate is an injected therapy designed to stop abnormal blood vessel growth and fluid leakage in the eye, which are major causes of vision loss.
- Headquarters
- Australia AU
- IPO date
- Apr 9, 1985
Financials
Efficiency
Earnings Waterfall
Opthea Ltd
Opthea Ltd